Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)

NCT00636558 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Breast Cancer
Prostate Cancer

Interventions

DRUG: CVA21

Sponsor

Viralytics